Long-term muscarinic inhibition increases intrinsic excitability through the upregulation of A-type potassium currents in cortical neurons. [PDF]
Riquelme D+4 more
europepmc +1 more source
Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors. [PDF]
Nielsen BE, Ford CP.
europepmc +1 more source
Muscarinic Receptors in Cardioprotection and Vascular Tone Regulation. [PDF]
Dolejší E, Janoušková A, Jakubík J.
europepmc +1 more source
Xanomeline-trospium (CobenfyTM) for Schizophrenia: A Review of the Literature. [PDF]
Smith CM+6 more
europepmc +1 more source
Bridging cholinergic signalling and inflammation in schizophrenia. [PDF]
Metz CN, Brines M, Pavlov VA.
europepmc +1 more source
The novel orthosteric agonist M1 muscarinic acetylcholine receptor reveals anti-Alzheimer's disease activity. [PDF]
Taheri M, Afzali Mehr M, Ghafouri H.
europepmc +1 more source
Acetylcholine muscarinic M2 receptor maintains human Schwann-like adipose-derived phenotype in the absence of differentiating medium. [PDF]
Piovesana R, Faroni A, Tata AM, Reid AJ.
europepmc +1 more source
The Role of Muscarinic Acetylcholine Receptor M3 in Cardiovascular Diseases. [PDF]
Liu X, Yu Y, Zhang H, Zhang M, Liu Y.
europepmc +1 more source